HL7 vs FHIR: Key Differences, Benefits, and Choosing the Right Standard in 2025
Introduction
HL7 (specifically HL7 v2) is a message-based standard from the late 1980s that moves batches of delimited data – segments and fields – over MLLP connections; it still powers roughly 80% of bedside interfaces like ADT, lab, and pharmacy messaging. FHIR (Fast Healthcare Interoperability Resources), introduced in 2014, is resource-based: each patient, observation, or medication is a self-contained JSON or XML object you can call over standard web APIs (REST, OAuth 2.0). The short version – HL7 v2 is the reliable legacy workhorse for internal, real-time bedside messaging; FHIR is the modern standard for APIs, mobile apps, and external data exchange. Most healthcare organizations run both today, not one or the other.
HL7 v2, HL7 v3, and FHIR
| HL7 v2 | HL7 v3 / CDA | FHIR | |
|---|---|---|---|
| Structure | Segment-based, delimited messages | Model-centric, document-based (CDA) | Resource-based (JSON/XML objects) |
| Transport | MLLP over TCP | Document exchange, varies | HTTP/HTTPS, REST |
| Security | No built-in security | Varies by implementation | OAuth 2.0, modern web auth |
| Extensibility | Custom “Z-segments” (can break parsers) | Rigid reference model | Formal extension framework (safe to ignore unknowns) |
| Primary use today | Bedside interfaces: ADT, orders/results, lab | Discharge summaries, government/legal reporting | APIs, mobile apps, patient portals, national exchange networks |
| Learning curve | Steep — segment grammar takes weeks to learn | Very steep — largely superseded | Days to prototype with open-source servers (e.g., HAPI FHIR) |
| Adoption today | Still dominant for internal bedside messaging | Niche (CDA specifically) | Rapidly growing, mandated for patient-facing APIs |
When to Use HL7 v2 vs. FHIR: A Decision Framework
on’t start with “which standard is better” – start with what the interface actually needs to do.
Lean toward HL7 v2 when:
- The interface is internal, bedside, and already stable (ICU monitoring, existing ADT/lab feeds)
- Sub-second latency matters more than API flexibility
- You’re not exposing this data externally or to third-party developers
Lean toward FHIR when:
- You’re building a patient-facing app, portal, or anything requiring SMART on FHIR / OAuth-secured access
- A regulatory mandate applies (the ONC Cures Act’s API-access requirements point directly at FHIR)
- External developers or partners need to consume your data
- You want a standard that’s actively extending into new domains (clinical decision support, genomics)
Use both when: you have a mature HL7 v2 environment and a growing need for external API access — which describes most mid-size and large health systems today. The realistic 2026 answer isn’t “migrate everything,” it’s “orchestrate both, and have a plan for which new interfaces default to FHIR.”
Migrating from HL7 v2 to FHIR Without a Rip-and-Replace
A phased, coexistence-based migration avoids the two failure modes organizations hit most often: trying to convert everything at once (high risk, long downtime windows) or never starting because a full migration feels too large.
- Inventory first. Map every inbound/outbound HL7 v2 feed and its FHIR equivalent (ADT ? Patient/Encounter, ORU ? Observation). This step alone often surfaces duplicate or redundant data flows worth retiring outright.
- Pilot in a sandbox. Stand up a read-only FHIR server for one low-risk domain — patient demographics is a common starting point.
- Build a translation layer. Use an integration engine to convert inbound HL7 v2 messages into FHIR resources in real time, rather than requiring source systems to change first.
- Dual-write during transition. Write to both the legacy HL7 queue and the new FHIR endpoint simultaneously, with automated regression tests comparing payloads before and after conversion.
- Decommission gradually. Retire each legacy interface only after the FHIR equivalent shows a clean error-free window – commonly 30 days – and downstream consumers have moved over.
This is the same pattern most health systems that have successfully modernized describe: a multi-month, phased migration rather than a single cutover, with cost savings and faster third-party onboarding as the typical payoff once complete.
How Vorro Supports Both Standards During Transition
Vorro is built for exactly this hybrid reality — most healthcare organizations aren’t choosing HL7 v2 or FHIR, they’re running both simultaneously for years. Vorro’s platform:
- Translates HL7 v2 messages into FHIR resources in real time, without requiring you to rebuild source systems
- Supports dual-write patterns so legacy and modern consumers can run in parallel during migration
- Provides native FHIR R4 support alongside mature HL7 v2 handling, so you’re not choosing a vendor twice as your standards mix shifts
- Gives you visibility into which interfaces are still HL7-dependent, so migration prioritization is based on actual usage, not guesswork
Adoption Landscape in 2025
Regulatory drivers
The ONC Cures Act now mandates API?based access to patient data, and that language points directly at FHIR. Across the Atlantic, the EU eHealth network has adopted FHIR as the standard for cross?border exchange, pushing vendors to certify compliance.
Industry adoption statistics
According to a 2024 HIMSS survey, 62?% of large health systems have at least one production FHIR server, up from 38?% in 2022. Meanwhile, 87?% still run HL7 V2 for core bedside interfaces. The overlap is growing, creating a hybrid reality.
Vendor support and tooling
Major EHR vendors like Epic and Cerner now ship FHIR endpoints out of the box, and open?source projects such as HAPI and Microsoft’s FHIR Server provide free stacks for startups. HL7 tools like the HAPI?V2 parser remain popular for legacy bridges.
Not Sure Where Your Organization Stands?
The right HL7-vs-FHIR strategy depends on your current interface inventory, regulatory timeline, and integration team capacity – not a generic recommendation.
Request an integration assessment to map your current HL7/FHIR mix, or talk to an integration engineer about a phased migration plan.
Frequently Asked Questions
What are the main differences between HL7 V2 messaging and FHIR resources?
HL7 v2 uses a segment-based, delimited message format transmitted over protocols like MLLP, while FHIR is built on modular, RESTful resources exchanged as JSON or XML. HL7 v2 messages are tightly coupled to a specific workflow; FHIR resources are designed to be reusable across many use cases.
Which standard is better for real time data exchange in healthcare?
For event-driven, API-based scenarios, FHIR’s RESTful design and HTTP/HTTPS support make it a more natural fit than HL7 v2’s batch-oriented MLLP transport. That said, existing, well-tuned HL7 v2 interfaces can still meet strict real-time thresholds for use cases like ICU monitoring.
How does FHIR handle versioning compared to HL7 V3/CDA?
FHIR assigns a version identifier to each resource instance and supports conditional updates, making change tracking explicit at the endpoint level. HL7 v3/CDA embeds version information in the document header but doesn’t offer the same granular, per-resource version control.
Can HL7 V2 messages be converted to FHIR without losing data?
Conversion tools can map most HL7 v2 segments to FHIR resources, but custom or locally defined fields (Z-segments) may need formal extensions or may not have a direct FHIR equivalent. Careful mapping and validation during migration is what preserves clinical intent.
What factors should organizations consider when choosing between HL7 and FHIR in 2025?
Your existing technology stack, the scope of interoperability you need (internal vs. external-facing), your team’s developer expertise, and applicable regulatory timelines (like Cures Act API mandates). Organizations with heavy legacy investment often keep HL7 v2 for internal messaging while defaulting new external-facing interfaces to FHIR – rather than treating it as an either/or decision.
